{"id":36932,"date":"2020-09-25T09:00:00","date_gmt":"2020-09-25T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&p=36932"},"modified":"2023-09-06T17:54:06","modified_gmt":"2023-09-06T15:54:06","slug":"ipsen-appoints-philippe-lopes-fernandes-as-executive-vice-president-chief-business-officer","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-appoints-philippe-lopes-fernandes-as-executive-vice-president-chief-business-officer\/","title":{"rendered":"Ipsen appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer"},"content":{"rendered":"

PARIS, France,<\/b> 25 September 2020 \u2014<\/b> Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer, effective 1 October 2020. Based in Cambridge, Massachusetts, USA, he will be responsible for business development and alliance management, reporting directly to David Loew, CEO, Ipsen. Philippe will serve on the Executive Leadership Team.
\n\u201cAs Chief Business Officer, Philippe will play a crucial role in our external innovation strategy. The ELT and I are delighted to welcome Philippe to Ipsen and look forward to working closely with him. His extensive and impressive track record in international business development, his outstanding reputation and his ability to work closely with the scientific community around the world will be a tremendous asset as we continue to develop our position as a global biopharmaceutical leader via external innovation. I know Philippe will make significant contributions to our existing network of robust partnerships and will help us further strengthen our pipeline,\u201d<\/em> said David Loew, CEO, Ipsen.
\n\u201cI\u2019m excited to be joining Ipsen at this pivotal moment,\u201d said Philippe Lopes-Fernandes. \u201cWorking closely with David, the ELT and the Business Development team, I look forward to further strengthening Ipsen\u2019s alliances across its therapeutic areas to help achieve our vision of serving patients with high unmet medical needs.\u201d<\/em>
\nPrior to joining Ipsen, Philippe worked at Merck KGaA where he was the Senior Vice President, Global Head of Business Development and Alliance Management, based in Cambridge (US). Before that, he held a variety of roles at Merck KGaA in Business Development, Mergers & Acquisitions, Finance and Marketing in France, Portugal, Germany, the United States and Switzerland.
\nPhilippe received his degree from the Institut Sup\u00e9rieur de Gestion (ISG) in Paris in 1994. He is a French External Trade advisor (Conseiller du Commerce Ext\u00e9rieur) and board member of several companies.
\nHe will continue to be based in Cambridge (USA).<\/p>\n

Attachment<\/strong><\/p>\n